Abstract:Objective To evaluate three different tracer-kinetic models used for dynamic contrast-enhanced MRI (DCE-MRI) data processing in the prediction of the histopathologic grade of cerebral gliomas.Methods Forty-one patients with histopathologically graded gliomas (grade Ⅱ 13,grade Ⅲ 14,grade Ⅳ 14)were imaged with DCE-MRI from March,2013 to November,2014.The values of Ktrans of gliomas were obtained by three tracer-kinetic models,which were Patlak model,Tofts model and Extended Tofts Linear model.All data were analyzed statistically by a Graphpad 6.0 statistical software.Comparison of the differences of Ktrans among different grades of gliomas was conducted using the Kruskal-Wallis test and Dunn's multiple comparisons test for the data not conform to normal distribution.Correlations of Ktrans values among those three models were analyzed using linear regression analysis,The differences of Ktrans between low grades and high grades of gliomas was conducted using the Mann-Whitney U test.Receiver operating characteristic (ROC) curve analyses were performed to determine the cut-off values for Ktrans to distinguish different low grades and high grades of gliomas.Results The Ktrans values obtained by Patlak model was 0.008(0.004-0.043) min-1for grade Ⅱ,0.021(0.005-0.088) min-1 for grade Ⅲ,and 0.035(0.017-0.061) min-1 for grade Ⅳ.The Ktrans values obtained by Tofts model was 0.085 (0.041-0.158)min 1for grade Ⅱ,0.140 (0.063-0.315) min-1for grade Ⅲ,0.229 (0.126-0.419)min 1 for grade Ⅳ.The Ktrans values obtained by Extended Tofts Linear model was 0.012 (0.004-0.092) min 1 for grade Ⅱ,0.048 (0.010-0.188) min-t for grade Ⅲ,0.094 (0.036-0.215)min 1 for grade Ⅳ.All the Ktrans values obtained by three models increased when the histological grades increased,with statistical significance between grade Ⅱ and Ⅲ (H=18.31,18.09,20.18,P＜0.05).Ktrans values among the three models had good linear correlations.The Ktrans obtained by Extended Tofts Linear model had good linear correlations with both Patlak model and Tofts model (r=0.933,0.893,P＜0.05),and the Ktrans obtained by Patlak model had less linear correlation with Tofts model (r=0.822,P＜0.05).The K values were statistically different between LGG and HGG (P＜0.01).The cut-off value of K provided good combination of sensitivity and specificity in the differentiation between LGG and HGG,and the K obtained by Extended Tofts Linear model had the best sensitivity and specificity among the three models (sensitivity 92.3％,specificity 85.7％).Conclusions K from DCE-MRI has a high performance in predicting the histopathologic grade of brain glioma,and the Extended Tofts Linear model is more suitable for the evaluation of cerebral glioma.

Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.

Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI

Differentiation of tuberculosis and metastatic cancer in the spine using dynamic contrast-enhanced MRI

Diagnosis of Spinal Lesions Using Perfusion Parameters Measured by DCE-MRI and Metabolism Parameters Measured by PET/CT

Dynamic Contrast-enhanced MRI in Identification and Diagnosis of Metastasis of Lung Cancer

Contrast-enhanced Digital Subtraction MRI in Vertebral Metastases

3T Dynamic Contrast Enhanced MR in Differential Diagnosis of Myeloma and Metastases in Spine

Use of monoexponential diffusion-weighted imaging and diffusion kurtosis imaging and dynamic contrast-enhanced-MRI for the differentiation of spinal tumors

Using Dynamic Contrast-Enhanced MRI to Predict the Histopathologic Grade of Cerebral Gliomas

Quantitative Investigation Of Solitary Pulmonary Nodules: Dynamic Contrast-Enhanced Mri And Histopathologic Analysis

Utility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiating Glioblastoma, Primary Central Nervous System Lymphoma and Brain Metastatic Tumor.

[Feasibility Study of Dynamic Contrast Enhanced Magnetic Resonance Imaging Qualitative Diagnosis of Musculoskeletal Tumors].

Discrimination between benign and malignant lung lesions using volumetric quantitative dynamic contrast-enhanced MRI

Dynamic Contrast-Enhanced MRI for the Assessment of Spinal Tumor Vascularity: Correlation with Angiography

Intravoxel Incoherent Motion to Differentiate Spinal Metastasis: A Pilot Study.

Differentiation between cerebral metastases , meningiomas , and primary gliomas by dynamic contrast-enhanced MRI

Tumor Infiltration of Bone Marrow in Patients with Hemato-Logical Malignancies: Dynamic Contrast-Enhanced Magnetic Resonance Imaging

The use of dynamic contrast enhanced MRI in differentiating between benign and malignant breast tumors and predicting the histologic grade for breast cancer patients

Dynamic Contrast-Enhanced MRI Differentiates Hepatocellular Carcinoma from Hepatic Metastasis of Rectal Cancer by Extracting Pharmacokinetic Parameters and Radiomic Features

A Clinically Feasible Method to Estimate Pharmacokinetic Parameters in Breast Cancer